Dracen Pharmaceuticals
Whitehawk Therapeutics Appoints Margaret Dugan as Chief Medical Officer
Whitehawk Therapeutics; Margaret Dugan; Chief Medical Officer; CMO; oncology; ADC; drug development; clinical trials; Novartis; Dracen Pharmaceuticals; Schrödinger